Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
The Evidence for Evolution02:55

The Evidence for Evolution

48.3K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.3K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

328
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
328
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

333
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ulipristal acetate for use in medical management of early pregnancy loss: a pilot feasibility study.

BMC pregnancy and childbirth·2026
Same author

Endometrial thickness in patients with postmenopausal bleeding and endometrial cancer: A retrospective cohort study.

Gynecologic oncology reports·2026
Same author

Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer.

Gynecologic oncology·2026
Same author

The impact of legislative changes on abortion care: A retrospective study of one hospital system in North Carolina.

Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives·2026
Same author

Pregnancy outcomes among medically complex populations with high risk of pregnancy mortality in Virginia: a retrospective observational study.

BMC medicine·2026
Same author

Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer.

Obstetrics and gynecology·2026

Related Experiment Video

Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Evidence-based pregnancy testing in clinical trials: Recommendations from a multi-stakeholder development process.

Jessica E Morse1, Sara B Calvert2, Claire Jurkowski3

  • 1Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.

Plos One
|September 13, 2018
PubMed
Summary
This summary is machine-generated.

Clinical trials often exclude pregnant women due to safety concerns. New recommendations provide evidence-based guidance for pregnancy testing in research, aiming to protect participants and improve trial efficiency.

More Related Videos

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K

Area of Science:

  • Clinical Research
  • Reproductive Health
  • Medical Ethics

Background:

  • Exclusion of pregnant women from clinical trials is common practice to prevent potential embryonic/fetal harm.
  • Lack of standardized pregnancy testing guidelines leads to inconsistent participant protection and research inefficiencies.
  • The Clinical Trials Transformation Initiative (CTTI) addressed the need for evidence-based pregnancy testing recommendations.

Purpose of the Study:

  • To develop and present recommendations for appropriate pregnancy testing in clinical research.
  • To establish standardized guidelines for identifying early pregnancy in research participants.
  • To balance participant safety with research integrity and efficiency.

Main Methods:

  • Convening content experts and stakeholders to review existing evidence.
  • Developing recommendations based on a comprehensive assessment of risks and burdens.
  • Creating an online tool to aid in the implementation of guidelines.

Main Results:

  • Protocols should clearly define the rationale and procedures for pregnancy testing, including handling of positive/indeterminate results.
  • Assessment of pregnancy testing plans must weigh benefits (reduced exposure risk) against burdens (participant, workload, cost).
  • Participant burdens, including false negative/positive rates, and the limitations of testing must be considered.

Conclusions:

  • Participant-administered home pregnancy testing should be avoided in clinical trials.
  • The informed consent process must detail potential risks to the embryo/fetus and the implications of pregnancy testing.
  • These recommendations aim to standardize pregnancy testing, enhance safety, and reduce inefficiencies in clinical research.